TMCnet - World's Largest Communications and Technology Community



BUYINS.NET: Market Maker Surveillance Report. DVAX, FCX, PSSI, CIM, S, ILNS, Highest Net Sell Volume and Negative Price Friction For Tuesday, February 19th 2013
[February 20, 2013]

BUYINS.NET: Market Maker Surveillance Report. DVAX, FCX, PSSI, CIM, S, ILNS, Highest Net Sell Volume and Negative Price Friction For Tuesday, February 19th 2013

(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET /, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3840 companies with "abnormal" market making, 3574 companies with positive Friction Factors and 2220 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Dynavax Technologies Corp (NASDAQ:DVAX), Freeport-McMoRan Copper & Gold Inc (NYSE:FCX), PSS World Medical Inc (NASDAQ:PSSI), Chimera Investment Corp (NYSE:CIM), Sprint Nextel Corp (NYSE:S), INTELLECT NEUROSCIENCES INC (OTC:ILNS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit .

Market Maker Friction Factor is shown in the chart below: Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction DVAX $-0.200 -6.35% 2,324,546 37.73% 3,820,560 62.01% -1,496,014 -74,801 FCX $-0.640 -1.81% 4,217,365 24.08% 5,561,373 31.76% -1,344,008 -21,000 PSSI $-0.020 -0.05% 659,139 19.62% 2,540,922 75.65% -1,881,783 -940,892 CIM $-0.080 -2.75% 6,449,791 29.35% 8,093,108 36.82% -1,643,317 -205,415 S $-0.010 -0.17% 5,441,805 29.37% 7,817,587 42.20% -2,375,782 -2,375,782 ILNS $-0.119 -88.15% 3,213,568 37.58% 5,337,046 62.42% -2,123,478 -178,444 Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows DVAX down $-0.20000 with a Friction Factor of -74,801 and a Net Volume of -1,496,014. That means that it takes 74,801 more shares of selling than buying to drop DVAX by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).

Dynavax Technologies Corp (NASDAQ:DVAX) - Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences. The company's lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. It is also developing Universal Flu vaccine, which is in Phase Ib clinical trial for influenza prevention; DV-601 that is in Phase Ib clinical trial for the treatment of hepatitis B infection; AZD1419, which is in preclinical stage for asthma therapy; and DV1179 that is in Phase I trial for autoimmune and inflammatory disease therapy. Dynavax Technologies Corporation has strategic alliance with GlaxoSmithKline plc to discover, develop, and commercialize toll-like receptor inhibitors; and research collaboration and license agreement with AstraZeneca to discover and develop TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California..

Freeport-McMoRan Copper & Gold Inc (NYSE:FCX) - Freeport-McMoRan Copper & Gold Inc. engages in the exploration, mining, and production of mineral resources. The company primarily explores for copper, gold, molybdenum, cobalt hydroxide, silver, and other metals, such as rhenium and magnetite. It holds interests in various mines located in the Grasberg minerals district in Indonesia; Morenci minerals district in North America; South America; and Tenke Fungurume minerals district in the Democratic Republic of Congo. As of December 31, 2011, the company s consolidated recoverable proven and probable reserves included 119.7 billion pounds of copper, 33.9 million ounces of gold, 3.42 billion pounds of molybdenum, 330.3 million ounces of silver, and 0.86 billion pounds of cobalt. Freeport-McMoRan Copper & Gold Inc. was founded in 1987 and is headquartered in Phoenix, Arizona..

PSS World Medical Inc (NASDAQ:PSSI) - PSS World Medical, Inc. provides medical products and supplies, diagnostic equipment, healthcare information technology, pharmaceutical products, and professional and consulting services in the United States. The company operates in two segments, Physician Business and Extended Care Business. The Physician Business segment distributes approximately 164,000 products, such as disposable supplies, pharmaceuticals, and diagnostic and non-diagnostic equipment, as well as offers healthcare information technology and physician dispensing solutions to office-based physicians specializing in internal medicine, family practice, primary care, pediatrics, OB/GYN, cardiology, orthopedics, general practice, and other specialties; and operating under the ownership of private or public companies or acute care facilities. As of March 30, 2012, this segment operated a distribution network comprising 33 full-service distribution centers, 39 break-freight locations, 2 other operations-related facilities, and 2 redistribution facilities. The Extended Care Business segment distributes approximately 46,000 medical and related products, such as medical supplies, incontinent supplies and personal care items, enteral feeding supplies, point of care testing devices, wound care, home medical equipment, and other supplies to independent, regional, and national nursing home facilities; home health agencies; assisted living centers; hospices; and home medical equipment dealers. This segment also offers its own store brands, including Select Medical Products and other specialty brand products; Medicare Part B and Medicaid billing services to the nursing home and assisted living market; and consulting services to extended care providers. It operated a distribution network consisting of 18 full-service distribution centers, 10 break-freight locations, 2 other operations-related facilities, and 2 redistribution facilities. The company was founded in 1983 and is based in Jacksonville, Florida..

Chimera Investment Corp (NYSE:CIM) - Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and other asset classes. Its targeted asset classes include agency or non-agency RMBS; prime, jumbo prime, and Alt-A mortgage loans; first or second lien loans secured by multifamily properties, mixed residential or other commercial properties, retail properties, office properties, or industrial properties; and asset-based securities (ABS), including commercial mortgage-backed securities, debt and equity tranches of collateralized debt obligations, and consumer and non-consumer ABS. The company has elected to be treated as a REIT for federal income tax purposes and would not be subject to income tax, if it distributes at least 90% of its REIT taxable income to its share holders. Chimera Investment Corporation was founded in 2007 and is based in New York, New York..

Sprint Nextel Corp (NYSE:S) - Sprint Nextel Corporation, together with its subsidiaries, offers wireless and wireline communications products and services to individual consumers, businesses, government subscribers, and resellers in the United States, Puerto Rico, and the United States Virgin Islands. It operates in two segments, Wireless and Wireline. The Wireless segment provides data transmission services, including mobile productivity applications, such as Internet access, messaging, and email services; wireless photo and video offerings; location-based capabilities comprising asset and fleet management, dispatch services, and navigation tools; mobile entertainment applications; and local and long distance wireless voice services, voicemail, call waiting, three-way calling, caller identification, directory assistance, and call forwarding services. This segment also provides customized design, development, implementation, and support for wireless services provided to large companies and government agencies, as well as sells accessories, such as carrying cases, hands-free devices, batteries, battery chargers, and other devices and accessories to subscribers, agents, and other third-party distributors for resale. The Wireline segment offers voice and data communications, including domestic and international data communications using various protocols, such as multiprotocol label switching technologies, Internet protocol, managed network services, voice over Internet protocol, session initiated protocol, and traditional voice services, as well as wholesale voice local and long distance, and digital voice services. This segment markets and sells its services primarily through direct sales representatives. The company offers its wireless and wireline voice and data transmission services under the Sprint, Nextel, Boost Mobile, Virgin Mobile, and Assurance Wireless brands. It serves approximately 56 million customers. The company was founded in 1899 and is headquartered in Overland Park, Kansas..

INTELLECT NEUROSCIENCES INC (OTC:ILNS) - Intellect Neurosciences, Inc., a biopharmaceutical company, engages in the discovery and development of proprietary drug candidates for the treatment of Alzheimer s disease and other diseases associated with oxidative stress. The company s drugs are based on its immunotherapy platform technologies, ANTISENILIN, RECALL-VAX, and CONJUMAB-A. Its product candidates include OX1, an orally-administered, brain-penetrating, and naturally-occurring copper-binding small molecule, which has completed Phase-I clinical trial for the treatment of Alzheimer s disease; IN-NO1, a preclinical humanized monoclonal antibody designed to prevent the accumulation of amyloid beta in the brain of Alzheimer s patients; and RV 01 and RV02 that are preclinical active vaccines for the treatment of Alzheimer s disease. The company has license agreements with University of South Alabama Medical Science Foundation, New York University, AHP Manufacturing BV, and ViroPharma; and collaboration agreement with MRC Technology and the University California. Intellect Neurosciences, Inc. was founded in 2005 and is based in New York, New York..

About BUYINS.NET BUYINS.NET, , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO INVESTMENTS & TRADING SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER: BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 CONTACT: Thomas Ronk ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to


[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy